Cash Flow Statement
Growth Metrics

Fresenius Medical Care AG (FMCQF) Gains from Sales and Divestitures (2016 - 2017)

Fresenius Medical Care AG (FMCQF) posted Gains from Sales and Divestitures of $32.2 million for Q4 2017, up 510.23% on a QoQ basis from $5.3 million in Q4 2016, and up 510.23% year-over-year from $5.3 million in Q4 2016.

Fresenius Medical Care AG (FMCQF) has 2 years of Gains from Sales and Divestitures data on file, last reported at $32.2 million in Q4 2017.

  • In Q4 2017, Gains from Sales and Divestitures rose 510.23% year-over-year to $32.2 million; the TTM figure through Dec 2017 stood at $32.2 million (up 510.23% YoY), while the FY2017 annual figure was $32.2 million, up 510.23% from the prior year.
  • Gains from Sales and Divestitures climbed to $32.2 million in Q4 2017, from $5.3 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $32.2 million in Q4 2017 and bottomed at $5.3 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Fresenius Medical Care AG - - 22,843.10 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2017 32.17 Mn
Dec 31, 2017 32.17 Mn
Dec 31, 2016 5.27 Mn
Dec 31, 2016 5.27 Mn